Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Consolidated Net Income: 2018-2024

Historic Consolidated Net Income for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Dec 2024 value amounting to -$80.9 million.

  • Arcturus Therapeutics Holdings' Consolidated Net Income fell 94.81% to -$13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.7 million, marking a year-over-year decrease of 6.57%. This contributed to the annual value of -$80.9 million for FY2024, which is 172.30% down from last year.
  • According to the latest figures from FY2024, Arcturus Therapeutics Holdings' Consolidated Net Income is -$80.9 million, which was down 172.30% from -$29.7 million recorded in FY2023.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Consolidated Net Income peaked at $9.3 million during FY2022, and registered a low of -$203.7 million during FY2021.
  • For the 3-year period, Arcturus Therapeutics Holdings' Consolidated Net Income averaged around -$33.8 million, with its median value being -$29.7 million (2023).
  • As far as peak fluctuations go, Arcturus Therapeutics Holdings' Consolidated Net Income surged by 104.59% in 2022, and later plummeted by 417.95% in 2023.
  • Arcturus Therapeutics Holdings' Consolidated Net Income (Yearly) stood at -$71.5 million in 2020, then plummeted by 184.76% to -$203.7 million in 2021, then soared by 104.59% to $9.3 million in 2022, then plummeted by 417.95% to -$29.7 million in 2023, then plummeted by 172.30% to -$80.9 million in 2024.